SYN-Tech Chem & Pharm Co Ltd (1777) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.099x

Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has a cash flow conversion efficiency ratio of 0.099x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.05 Million ≈ $8.07 Million USD) by net assets (NT$2.59 Billion ≈ $81.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of SYN-Tech Chem & Pharm Co Ltd to measure how many days the company can operate on defensive assets alone.

SYN-Tech Chem & Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SYN-Tech Chem & Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hyundai Everdigm Corp KQ:041440	-0.014x
Hammond Manufacturing Company Limited TO:HMM-A	0.058x
Hankook Cosmetics Manufacturing Co Ltd KO:003350	0.103x
MNtech Co. Ltd KQ:095500	0.089x
Eolus Vind AB (publ) ST:EOLU-B	0.793x
Fortune Oriental Co Ltd TW:2491	0.034x
Bulten AB ST:BULTEN	0.027x
Kootenay Silver Inc V:KTN	-0.025x

Annual Cash Flow Conversion Efficiency for SYN-Tech Chem & Pharm Co Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 1777 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.59 Billion ≈ $81.61 Million	NT$559.49 Million ≈ $17.63 Million	0.216x	-11.18%
2024-12-31	NT$2.56 Billion ≈ $80.66 Million	NT$622.61 Million ≈ $19.62 Million	0.243x	+114.86%
2023-12-31	NT$2.32 Billion ≈ $73.01 Million	NT$262.29 Million ≈ $8.26 Million	0.113x	-43.27%
2022-12-31	NT$2.20 Billion ≈ $69.29 Million	NT$438.81 Million ≈ $13.83 Million	0.200x	+152.09%
2021-12-31	NT$1.98 Billion ≈ $62.49 Million	NT$156.98 Million ≈ $4.95 Million	0.079x	-69.24%
2020-12-31	NT$1.24 Billion ≈ $39.08 Million	NT$319.21 Million ≈ $10.06 Million	0.257x	+30.86%
2019-12-31	NT$1.16 Billion ≈ $36.55 Million	NT$228.12 Million ≈ $7.19 Million	0.197x	+14.63%
2018-12-31	NT$1.10 Billion ≈ $34.62 Million	NT$188.49 Million ≈ $5.94 Million	0.172x	+298.39%
2017-12-31	NT$996.24 Million ≈ $31.39 Million	NT$42.89 Million ≈ $1.35 Million	0.043x	-81.19%
2016-12-31	NT$1.03 Billion ≈ $32.37 Million	NT$235.26 Million ≈ $7.41 Million	0.229x	+48.07%
2015-12-31	NT$969.06 Million ≈ $30.53 Million	NT$149.84 Million ≈ $4.72 Million	0.155x	--

About SYN-Tech Chem & Pharm Co Ltd

TWO:1777 Taiwan Biotechnology

Market Cap

$101.71 Million

NT$3.23 Billion TWD

Market Cap Rank

#19227 Global

#1091 in Taiwan

Share Price

NT$72.40

Change (1 day)

+0.00%

52-Week Range

NT$70.30 - NT$87.60

All Time High

NT$108.00